Taiwan Semiconductor ramps up global fabs in the United States, Japan, and Europe, but soaring investments raise pressure on margins in 2025 and beyond.

SINGAPORE, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Davis Commodities Limited (Nasdaq: DTCK), a Singapore-based agricultural trading company, today announced ongoing strategic reviews of tokenized yield instruments designed to extend the company's initiatives in commodity finance digitization. The approach under study expands on Davis Commodities' earlier assessments of Real Yield Tokenization (RYT), stablecoin settlement layers, and modular CFD structures, all aimed at connecting global agri-trade with programmable liquidity and ESG-aligned capital.

Viking Therapeutics (NASDAQ:VKTX) shares tumbled 43% on Tuesday following the release of data from its Phase 2a Venture Oral weight loss trial showing strong efficacy but raised tolerability concerns. The study showed that participants taking VK-2735 achieved placebo-adjusted weight losses of approximately 7.5% at 60 mg, 10% at 90 mg, and 11% at 120 mg over 13 weeks.

Outdoor style meets artistic expression in Chaco's biggest fan-powered design contest yet—with a $5,000 prize and a shot at sandal fame GRAND RAPIDS, Mich. , Aug. 19, 2025 /PRNewswire/ -- Chaco , leading outdoor sandal brand, is calling on its spirited #ChacoNation community to design the next iconic webbing in a brand-new contest: Designapalooza.

Viking Therapeutics, Inc.'s VK2735 oral trial met efficacy and safety endpoints, but high discontinuation rates and modest weight loss disappointed Wall Street, triggering a steep sell-off. Despite being underwhelming compared to Novo and Lilly's oral GLP-1 drugs, VK2735 remains a top-three candidate in a massive, rapidly growing obesity market. Phase 3 injectable VK2735 data will be more decisive, and the market's expectations for weight loss drugs may need to be reset to more realistic levels.

Andrew Ferguson, FTC Chair, joins 'Money Movers' to discuss the lawsuit filed against ticket resellers.

Archer ended Q2 2025 with $1.724 billion liquidity after an $850 million raise, funding certification and manufacturing. Six Midnight aircraft are under build, three in final assembly, across Archer's 700,000 sq. ft. combined facilities. Midnight completed a record 55-mile, 31-minute piloted flight at 126 mph, validating safety envelope and regulator confidence.

The U.S. Food and Drug Administration (FDA) on Monday extended its review timeline for REGENXBIO Inc.'s RGNX Biologics License Application (BLA) for clemidsogene lanparvovec (RGX-121) for Mucopolysaccharidosis II (MPS II), also known as Hunter syndrome.

Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.

IWM is gaining momentum as rate-cut hopes, attractive valuations and rising small-business optimism fuel renewed interest in small-cap ETFs.

Jessica Inskip expects Jackson Hole this week to be a big market mover. She also sees a potential path for interest rates during the meeting adding momentum to the homebuilder space, including Builders FirstSource (BLDR).

SEATTLE--(BUSINESS WIRE)--MCE Systems, the pioneer of digital-first mobile device lifecycle management (dDLM), today announced the appointment of Aleeta Willcuts, former Vice President of Retail Experience & Strategy at T-Mobile U.S., to its Board of Advisors. With more than 20 years of experience leading retail sales and operations, Aleeta will help accelerate MCE's combined retail and digital transformation proposition to mobile operators. “I really believe in MCE's advanced digital and r.

LOS ANGELES, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”).

LOS ANGELES , Aug. 19, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN).

New Campaign Launches Today Ahead of Unrated Film's Theatrical Release on August 29, 2025 – Because this Radioactive Mutant Superhero Won't Put Soda in His Body LOS ANGELES , Aug. 19, 2025 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, has launched a new campaign with Liquid Death, one of the fastest growing non-alcoholic beverage brands, for a unique brand partnership leading into the August 29, 2025 wide theatrical release of The Toxic Avenger Unrated . The core piece of the campaign launching today has a 'PSA' from Toxie himself (portrayed by Peter Dinklage ) about the dangers of …

BENSALEM, Pa. , Aug. 19, 2025 /PRNewswire/ -- The Law Offices of Howard G.

Shareholders with losses of $100,000 or more are encouraged to contact the firm. BENSALEM, Pa.

LOS ANGELES, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 26, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT) securities between January 23, 2024 and July 21, 2025, inclusive (the “Class Period”).

LOS ANGELES, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) securities between May 7, 2025, to July 28, 2025, inclusive (the “Class Period”).

BENSALEM, Pa. , Aug. 19, 2025 /PRNewswire/ -- The Law Offices of Howard G.